© 2021 MJH Life Sciences and Cancer Network. All rights reserved.
© 2021 MJH Life Sciences™ and Cancer Network. All rights reserved.
November 14, 2019
The US Food and Drug Administration recently approved alpelisib plus fulvestrant for the treatment of metastatic or otherwise advanced breast cancer.
Highlights of breast cancer advances at the ESMO Congress.
November 05, 2019
Researchers look at cost estimates stratified by stage, histology, and level of treatment.
October 28, 2019
This year has seen many advances in immunotherapy. Here is a look at some of the most significant research.
October 16, 2019
Researchers explore the predictive capability of EVI1 expression.
Researchers report on the BRIGHT AML 1019 Phase III trial.
A review of recent advances in the noninvasive imaging of immunotherapeutic targets.
October 07, 2019
Researchers look at how mutation status can influence responses to targeted therapy in thyroid cancer.
Genetic profiles of thyroid cancer shed light on molecular mechanisms.
September 24, 2019
Investigators assessed effects of TIB on cell number, migration, invasion, estrogen, and progesterone receptor activity and content.